Skip to main content

Table 1 Demographics and clinical characteristics of patients (N = 86)

From: Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Characteristics

N (%)

Sex

 Female

32 (37.2)

 Male

54 (62.8)

Age (years)

 ≥ 60

52 (60.5)

 < 60

32 (37.2)

 Unknown

2 (2.3)

Cohort

 Baseline

32 (37.2)

 MET-TKI

41 (47.7)

 EGFR-TKI

13 (15.1)

Stage at diagnosis

 I

1 (1.2)

 III

1 (1.2)

 IV

44 (51.1)

 Unknown

40 (46.5)

Histology

 ADC

63 (73.2)

 ASC

1 (1.2)

 SCC

2 (2.3)

 Unknown

20 (23.3)

  1. ADC adenocarcinoma, ASC adenosquamous carcinoma, SCC squamous cell carcinoma